Genomics Revolution in Indian Healthcare: From Wellness Craze to Standard of Care

Spread the Message

Read Time:4 Minute, 15 Second

The diagnostic and healthcare landscape in India is undergoing a transformative revolution, propelled by advances in genomics, next-generation sequencing (NGS), and precision medicine. Once dominated by walk-in labs and reactive care, the sector is shifting rapidly toward predictive and personalized healthcare driven by cutting-edge technology and growing patient awareness. Experts at the 5th Healthcare Leaders Summit highlighted how these innovations are poised to redefine wellness and become mainstream standards of care nationwide.

The journey from traditional diagnostics to a digital-first, home-based, and mobile-enabled ecosystem marks a seismic shift in how healthcare reaches patients. Dr. Om Manchanda, Former MD of Dr. Lal Path Labs, emphasized this transformation: “When I joined Dr. Lal, 80–90 per cent of our business came from walk-in clients. Today, people book tests online, provide samples at home, and access their reports on mobile devices without visiting a lab.” Beyond convenience, the paradigm shift extends into healthcare philosophy from prescriptive to preventive, and now predictive.

This predictive phase is powered by genomics-based diagnostic tools that identify genetic predispositions and risk factors long before symptoms appear. Dr. Manchanda added that the rise in awareness, driven by events such as the COVID-19 pandemic and increased understanding of comorbidities, is fueling demand for these insights. Predictive profiling now enables early disease detection and risk flagging, empowering individuals and clinicians to take preemptive action.

Integrating diagnostics is another frontier: breaking silos between specialties, such as combining genomics with imaging to deliver unified, precise diagnoses. Dr. Harsh Mahajan, founder of Mahajan Imaging, highlighted his center’s pioneering work integrating next-generation sequencing with radiology since 2016. “Patients want clear, consolidated insights—not fragmented data,” he said. This integrated approach is especially meaningful in complex conditions like cancer, cardiology, neurology, and diabetes.

The implications for public health are significant. Personalized healthcare plans—ranging from lifestyle adjustments to targeted therapies—promise improved treatment outcomes and prevention. For healthcare systems, this precision medicine model means fewer misdiagnoses, more efficient resource use, and a shift toward wellness rather than illness management. India’s large and diverse population, combined with rising patient literacy, positions the country well to adopt these advancements, though challenges like cost, rural accessibility, and public awareness remain.

The traditional “one-size-fits-all” diagnostic packages are increasingly obsolete. Dr. Arjun Dang, CEO of Dr. Dang’s Lab, criticized the cookie-cutter approach: “Many people still select tests based on family history and budget rather than personalized risk, missing vital insights. It’s like painting with broad brush strokes instead of fine lines.” His team developed Discover by Dr. Dangs, a digital tool that curates personalized diagnostic packages based on individual health goals, backed by peer-reviewed evidence. Over 7,000 customized check-ups have revealed marked variation in needs, even among younger adults, underscoring the necessity of bespoke testing.

Genomics is the engine driving this personalization. Dr. Sakthivel Murugan of MedGenome shared that their focus evolved from preventive diagnostics—such as mutation identification and prenatal checks—to predictive genomics. This shift is vital in oncology, where precision medicine matches patients to the most effective treatments based on genetic markers. MedGenome delivers polygenic risk scores for several disorders, including Parkinson’s disease and coronary artery disease, achieving over 90 percent predictive accuracy when combined with clinical data.

Despite enthusiasm, challenges persist. Global companies like 23andMe faced hurdles due to lacking large, validated databases and established guidelines. Indian experts stress the importance of rigorous validation and guidelines for predictive genomics to become reliable clinical tools. Policymakers are working to establish genomics centers of excellence and address data privacy, with firms adhering to strict GDPR-like norms ensuring genomic data remains confidential and patient-owned.

An additional frontier is combating antimicrobial resistance (AMR), termed a “silent pandemic.” Using bacteriophage sensitivity testing—where viruses target specific bacteria—genomics offers innovative solutions beyond conventional antibiotics. Such advances underscore genomics’ potential across health domains beyond wellness checks and cancer management.

Expert consensus confirms genomics and precision diagnostics—though sometimes seen as a current wellness trend—are becoming foundational in modern healthcare. As Dr. Mahajan summarized, “Precision medicine saves lives and will grow rapidly. Predictive medicine may take longer to fully embed due to human resistance to early risk knowledge. But genomics is no longer the future—it’s here now.”

For individuals, this means a healthcare future where your unique genetic profile informs personalized prevention and treatment plans. For society, it represents transformative potential to enhance outcomes, reduce costs, and focus on maintaining health rather than merely reacting to illness.

Medical Disclaimer: This article is for informational purposes only and should not be considered medical advice. Always consult with qualified healthcare professionals before making any health-related decisions or changes to your treatment plan. The information presented here is based on current research and expert opinions, which may evolve as new evidence emerges.

References: